UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

The Lancet (British edition), 2009-02, Vol.373 (9665), p.732-738

2009

Link zum Volltext

Verfügbarkeit prüfen

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis

Clinical therapeutics, 2007-09, Vol.29 (9), p.2031-2048

2007

Link zum Volltext

Verfügbarkeit prüfen

Pain associated with multiple sclerosis: Systematic review and proposed classification

Pain (Amsterdam), 2008-06, Vol.137 (1), p.96-111

2008

Link zum Volltext

Verfügbarkeit prüfen

Cognitive fatigue during a test requiring sustained attention: a pilot study

Multiple sclerosis, 2003-10, Vol.9 (5), p.503-508

2003

Link zum Volltext

Verfügbarkeit prüfen

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis

Clinical therapeutics, 2007-09, Vol.29 (9), p.2031-2048

2007

Link zum Volltext

Verfügbarkeit prüfen

Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis

Nature clinical practice. Neurology, 2009-02, Vol.5 (2), p.82-92

2009

Link zum Volltext

Verfügbarkeit prüfen

Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a

Neurology, 2005-12, Vol.65 (12), p.1964

2005

Link zum Volltext

Verfügbarkeit prüfen

Cognitive function in relapsing multiple sclerosis: Minimal changes in a 10-year clinical trial

Journal of the neurological sciences, 2007-04, Vol.255 (1), p.57-63

2007

Link zum Volltext

Verfügbarkeit prüfen

Fatigue in multiple sclerosis: current understanding and future directions

Journal of rehabilitation research and development, 2002-03, Vol.39 (2), p.211-224

2002

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled study of the acute and chronic effects of cooling therapy for MS

Neurology, 2003-06, Vol.60 (12), p.1955

2003

Link zum Volltext

Verfügbarkeit prüfen

Futility studies: spending a little to save a lot

Neurology, 2006-03, Vol.66 (5), p.626

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline

Movement disorders, 2006-10, Vol.21 (10), p.1716-1721

2006

Link zum Volltext

Verfügbarkeit prüfen

Urate as a predictor of the rate of clinical decline in Parkinson disease

Archives of neurology (Chicago), 2009-12, Vol.66 (12), p.1460

2009

Link zum Volltext

Verfügbarkeit prüfen

Transtelephonic Home Blood Pressure to Assess the Monoamine Oxidase-B Inhibitor Rasagiline in Parkinson Disease

Hypertension (Dallas, Tex. 1979), 2008-09, Vol.52 (3), p.587-593

2008

Link zum Volltext

Verfügbarkeit prüfen

Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease

Movement disorders, 2010-09, Vol.25 (12), p.1801-1808

2010

Link zum Volltext

Verfügbarkeit prüfen

Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome

Multiple sclerosis, 2008-04, Vol.14 (3), p.425-427

2008

Link zum Volltext

Verfügbarkeit prüfen

Treating fatigue in patients with MS: one step forward, one step back

Neurology, 2005-04, Vol.64 (7), p.1111

2005

Link zum Volltext

Verfügbarkeit prüfen

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

Archives of neurology (Chicago), 2008-06, Vol.65 (6), p.716

2008

Link zum Volltext

Verfügbarkeit prüfen

Broadening the spectrum of controls for skin biopsy in painful neuropathies

Muscle & nerve, 2010-09, Vol.42 (3), p.435-437

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study

Archives of neurology (Chicago), 2005-02, Vol.62 (2), p.241

Parkinson Study Group

2005

Link zum Volltext

Verfügbarkeit prüfen

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

Annals of neurology, 2009-10, Vol.66 (4), p.460-471

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison of mobility device delivery within Department of Veterans Affairs for individuals with multiple sclerosis versus spinal cord injury

Journal of rehabilitation research and development, 2007-01, Vol.44 (5), p.693-701

2007

Link zum Volltext

Verfügbarkeit prüfen

Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study

Archives of neurology (Chicago), 2005-05, Vol.62 (5), p.785

2005

Link zum Volltext

Verfügbarkeit prüfen

Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders

Journal of neuroimmunology, 1999-07, Vol.98 (1), p.29-36

1999

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of motor fatigue and strength in MS

Neurology, 1999-09, Vol.53 (4), p.743

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

ThemaDisability Evaluation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(40)
Buchkapitel
(1)

Sprache

Englisch
(41)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis

Pain associated with multiple sclerosis: Systematic review and proposed classification

Cognitive fatigue during a test requiring sustained attention: a pilot study

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis

Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis

Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a

Cognitive function in relapsing multiple sclerosis: Minimal changes in a 10-year clinical trial

Fatigue in multiple sclerosis: current understanding and future directions

A randomized controlled study of the acute and chronic effects of cooling therapy for MS

Futility studies: spending a little to save a lot

Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline

Urate as a predictor of the rate of clinical decline in Parkinson disease

Transtelephonic Home Blood Pressure to Assess the Monoamine Oxidase-B Inhibitor Rasagiline in Parkinson Disease

Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease

Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome

Treating fatigue in patients with MS: one step forward, one step back

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

Broadening the spectrum of controls for skin biopsy in painful neuropathies

A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

Comparison of mobility device delivery within Department of Veterans Affairs for individuals with multiple sclerosis versus spinal cord injury

Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study

Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders

Quantitative assessment of motor fatigue and strength in MS

Aktive Filter

Suchergebnisse filtern